IL92225A0 - Delivery systems containing aminopolysaccharide derivatives for the delivery of pharmaceutically active materials - Google Patents

Delivery systems containing aminopolysaccharide derivatives for the delivery of pharmaceutically active materials

Info

Publication number
IL92225A0
IL92225A0 IL92225A IL9222589A IL92225A0 IL 92225 A0 IL92225 A0 IL 92225A0 IL 92225 A IL92225 A IL 92225A IL 9222589 A IL9222589 A IL 9222589A IL 92225 A0 IL92225 A0 IL 92225A0
Authority
IL
Israel
Prior art keywords
delivery
aminopolysaccharide
derivatives
pharmaceutically active
active materials
Prior art date
Application number
IL92225A
Other languages
English (en)
Original Assignee
Union Carbide Chem Plastic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Carbide Chem Plastic filed Critical Union Carbide Chem Plastic
Publication of IL92225A0 publication Critical patent/IL92225A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0076—Sprayable compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/06—Organic material
    • B01D71/08—Polysaccharides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5426—Polymers characterized by specific structures/properties characterized by the charge cationic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S261/00—Gas and liquid contact apparatus
    • Y10S261/88—Aroma dispensers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/15—Suppositories

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL92225A 1988-11-08 1989-11-06 Delivery systems containing aminopolysaccharide derivatives for the delivery of pharmaceutically active materials IL92225A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/268,871 US4946870A (en) 1986-06-06 1988-11-08 Delivery systems for pharmaceutical or therapeutic actives

Publications (1)

Publication Number Publication Date
IL92225A0 true IL92225A0 (en) 1990-07-26

Family

ID=23024862

Family Applications (1)

Application Number Title Priority Date Filing Date
IL92225A IL92225A0 (en) 1988-11-08 1989-11-06 Delivery systems containing aminopolysaccharide derivatives for the delivery of pharmaceutically active materials

Country Status (7)

Country Link
US (1) US4946870A (fr)
EP (1) EP0368253A3 (fr)
JP (1) JPH02196728A (fr)
KR (1) KR940002657B1 (fr)
AU (1) AU625075B2 (fr)
CA (1) CA2002404A1 (fr)
IL (1) IL92225A0 (fr)

Families Citing this family (200)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300494A (en) * 1986-06-06 1994-04-05 Union Carbide Chemicals & Plastics Technology Corporation Delivery systems for quaternary and related compounds
US5690954A (en) * 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
US5234959A (en) * 1988-04-08 1993-08-10 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
US5702716A (en) * 1988-10-03 1997-12-30 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5725491A (en) * 1988-10-03 1998-03-10 Atrix Laboratories, Inc. Method of forming a biodegradable film dressing on tissue
US5632727A (en) * 1988-10-03 1997-05-27 Atrix Laboratories, Inc. Biodegradable film dressing and method for its formation
US5474989A (en) * 1988-11-11 1995-12-12 Kurita Water Industries, Ltd. Drug composition
LU87410A1 (fr) * 1988-12-20 1990-07-10 Cird Composition cosmetique ou pharmaceutique contenant des microspheres de polymeres ou de corps gras chargees d'au moins un produit actif
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
US5744166A (en) * 1989-02-25 1998-04-28 Danbiosyst Uk Limited Drug delivery compositions
US5554388A (en) * 1989-02-25 1996-09-10 Danbiosyst Uk Limited Systemic drug delivery compositions comprising a polycationi substance
DE3910543A1 (de) * 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
FR2649888B1 (fr) * 1989-07-18 1994-08-26 Exsymol Sa Produits pour applications cutanees, a effets cosmetiques ou/et therapeutiques
US5487897A (en) 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
CA1340994C (fr) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Traitement de maladies et d'etats pathologiques
US5639738A (en) * 1992-02-20 1997-06-17 Hyal Pharmaceutical Corporation Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
CA2061566C (fr) * 1992-02-20 2002-07-09 Rudolf E. Falk Traitement des maladies par l'acide hyaluronique et des ains
CA2061703C (fr) * 1992-02-20 2002-07-02 Rudolf E. Falk Compositions renfermant de l'acide hyaluronique
IT1243745B (it) * 1990-10-17 1994-06-21 Vectorpharma Int Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
GB9022788D0 (en) * 1990-10-19 1990-12-05 Cortecs Ltd Pharmaceutical formulations
WO1992009636A1 (fr) * 1990-11-30 1992-06-11 Baker Cummins Dermatologicals, Inc. Compositions de protection de la peau et procede d'inhibition de l'irritation de la peau
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
IT1247472B (it) * 1991-05-31 1994-12-17 Fidia Spa Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
US5817644A (en) * 1991-07-03 1998-10-06 Hyal Pharmaceutical Corporation Targeting of dosages of medicine and therapeutic agents
WO1994007505A1 (fr) * 1991-07-03 1994-04-14 Norpharmco Inc. Utilisation de l'acide hyaluronique sous differentes formes contre la recidive de la stenose arterielle
US5792753A (en) * 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
US5990095A (en) * 1991-07-03 1999-11-23 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
JPH06509099A (ja) * 1991-07-03 1994-10-13 サノ・コーポレーシヨン ジクロフエナツクの経皮デリバリーに対する組成物及び方法
US6022866A (en) * 1991-07-03 2000-02-08 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
AU2605592A (en) * 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US6136793A (en) * 1992-02-20 2000-10-24 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6114314A (en) * 1992-02-21 2000-09-05 Hyal Pharmaceutical Corp. Formulations containing hyaluronic acid
EP0560014A1 (fr) * 1992-03-12 1993-09-15 Atrix Laboratories, Inc. Pansement sous forme de film biodégradable et méthode pour sa fabrication
ATE218330T1 (de) * 1992-03-23 2002-06-15 Univ Manitoba Verwendung von transglutaminasehemmer zur behandlung des narbegewebes
US5618515A (en) * 1992-08-19 1997-04-08 Blistex Inc. Aerosol spray composition for the treatment of dermal burns by cooling and anesthetizing the wound and valved container for dispensing same
DE4328329C2 (de) * 1992-08-26 1998-02-12 Suwelack Nachf Dr Otto Gefriergetrocknete Biomatrix
US6001340A (en) * 1993-03-30 1999-12-14 Steven E. Rosen Topical compositions and methods for treating Pseudofolliculitis barbae and ingrown hair
US5688495A (en) * 1993-03-30 1997-11-18 Rosen; Steven E. Topical deodorant compositions
US6703009B1 (en) * 1993-03-30 2004-03-09 Tendskin International Inc. Topical compositions and methods for treating pseudofolliculitis barbae and ingrown hair
US5951531A (en) * 1993-04-20 1999-09-14 Medchem Products, Inc. Apparatus and method for applying a particulate hemostatic agent to living tissue
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US5407919A (en) * 1993-09-29 1995-04-18 Brode; George L. Double-substituted cationic cellulose ethers
ZA947572B (en) * 1993-09-29 1995-09-28 Hampton Roads Medical College Contraceptive compositions
US5681873A (en) * 1993-10-14 1997-10-28 Atrix Laboratories, Inc. Biodegradable polymeric composition
HRP950149A2 (en) * 1994-04-13 1997-06-30 Janssen Pharmaceutica Nv Intranasal antimigrene composition
US6054462A (en) * 1994-04-13 2000-04-25 Janssen Pharmaceutica, N.V. Intranasal antimigraine compositions
US20010053359A1 (en) * 1994-07-26 2001-12-20 Peter Watts Drug delivery composition for the nasal administration of antiviral agents
GB9414966D0 (en) * 1994-07-26 1994-09-14 Danbiosyst Uk Pharmaceutical compositions for the nasal administration of antiviral agents
US5597811A (en) * 1995-04-10 1997-01-28 Amerchol Corporation Oxirane carboxylic acid derivatives of polyglucosamines
US5722950A (en) * 1995-06-07 1998-03-03 Atrix Laboratories, Inc. Method for remote delivery of an aerosolized liquid
US6150581A (en) * 1995-06-07 2000-11-21 United States Surgical Corporation Chitosan/alginate anti-adhesion barrier
JPH11507697A (ja) * 1995-06-09 1999-07-06 エヌ． ドロハン，ウィリアム キチンヒドロゲル、それらの製造方法及び利用
US5866142A (en) * 1995-07-20 1999-02-02 Riordan; Neil H. Skin treatment system
TW389694B (en) * 1995-08-17 2000-05-11 Novartis Ag Compositions including o-carboxyalkyl chitosan and methods of use in ophthalmics
US5736532A (en) * 1996-02-14 1998-04-07 Furda; Ivan Multifunctional fat absorption and blood cholesterol reducing formulation comprising chitosan
KR970061240A (ko) * 1996-02-26 1997-09-12 이우용 간에서 초회통과 효과를 받는 약물의 직장투여용 조성물
US5888494A (en) * 1996-03-12 1999-03-30 Adolor Corporation Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith
US5667773A (en) * 1996-03-12 1997-09-16 Adolor Corporation Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic conditions therewith
KR970064596A (ko) * 1996-03-21 1997-10-13 이우용 직장투여용 치질치료제 조성물
WO1997034580A1 (fr) * 1996-03-21 1997-09-25 Dong Wha Pharmaceutical Industrial Co., Ltd. Composition pour suppositoires d'un medicament provoquant, en cas d'administration orale, des troubles gastro-intestinaux ou se decomposant sous l'effet de l'acide gastrique
US6060045A (en) * 1996-04-08 2000-05-09 Mettler; Leo Vitaminized air freshener and room deodorizer pad
US5891427A (en) * 1996-04-08 1999-04-06 Mettler; Leo Vitaminized air freshner and room deodorizer
US6562326B1 (en) * 1996-08-12 2003-05-13 Bruce W. Miller Topical composition for burn healing
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) * 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US6706690B2 (en) 1999-06-10 2004-03-16 Baxter Healthcare Corporation Hemoactive compositions and methods for their manufacture and use
US7871637B2 (en) 1996-08-27 2011-01-18 Baxter International Inc. Dry hemostatic compositions and methods for their preparation
US7320962B2 (en) 1996-08-27 2008-01-22 Baxter International Inc. Hemoactive compositions and methods for their manufacture and use
US6066325A (en) * 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US5965545A (en) * 1996-10-15 1999-10-12 State Of Israel, Ministry Of Agriculture, Agricultural Research Organization, The Volcani Center Compositions and method for controlling fungal disease in plants
SE9604610D0 (sv) * 1996-12-16 1996-12-16 Noviscens Ab Medical composition
US6126919A (en) * 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
CA2208916A1 (fr) * 1997-07-03 1999-01-03 Hyal Pharmaceutical Corporation Promotion de la cicatrisation a l'aide de steroides ayant des effets secondaires systemiques reduits comparativement a ceux habituellement associes aux glucocorticoides, aux mineralcorticoides et aux steroides sexuels
US6391336B1 (en) 1997-09-22 2002-05-21 Royer Biomedical, Inc. Inorganic-polymer complexes for the controlled release of compounds including medicinals
US7128927B1 (en) 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
EP1113814A1 (fr) * 1998-09-17 2001-07-11 Zonagen, Inc. Vaccins a la gonadotrophine chorionique
PT1123082E (pt) * 1998-10-23 2006-06-30 Aventis Pharma Sa Preparacoes para aplicacao topica de substancias de actividade antiandrogenica
DE19850734A1 (de) * 1998-11-04 2000-05-11 Henkel Kgaa Alkoholische kosmetische Zubereitungen
US6503488B1 (en) 1998-11-17 2003-01-07 Tend Skin International, Inc. Topical compositions including deodorant compositions
DE69928013T2 (de) 1998-11-24 2006-07-27 Safescience, Inc., Boston Chitosan-metall-komplexe und sie verwendende verfahren zur bekämpfung von mikrobiellem wachstum auf pflanzen
EP1158957A4 (fr) 1999-02-24 2004-12-15 Dong Wha Pharm Ind Co Ltd Composition de suppositoire liquide au diclofenac sodique
GB9905425D0 (en) * 1999-03-09 1999-05-05 Queen Mary & Westfield College Pharmaceutical composition
US6093386A (en) * 1999-03-25 2000-07-25 Sampino; Andrew Shaving and skin conditioning lotion
US6645947B1 (en) 1999-05-20 2003-11-11 Chitogenics, Inc. Adhesive N, O-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins
US8226598B2 (en) 1999-09-24 2012-07-24 Tolmar Therapeutics, Inc. Coupling syringe system and methods for obtaining a mixed composition
US20030206958A1 (en) * 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
US6451773B1 (en) * 2000-03-31 2002-09-17 Cognis Corporation Chitosan formulation with azelaic acid and other actives for the treatment of acne
US6579544B1 (en) 2000-05-31 2003-06-17 Nutriex, L.L.C. Method for supplementing the diet
US6420352B1 (en) * 2000-07-19 2002-07-16 W. Roy Knowles Hair loss prevention
WO2002007674A2 (fr) * 2000-07-21 2002-01-31 Ceramoptec Industries, Inc. Amelioration de la penetration d'un compose dans et a travers des follicules pileux
DE10035991A1 (de) * 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US6497901B1 (en) 2000-11-02 2002-12-24 Royer Biomedical, Inc. Resorbable matrices for delivery of bioactive compounds
US20020058704A1 (en) * 2000-11-15 2002-05-16 Kimberly-Clark Worldwide, Inc. Multicomponent compositions containing chitosan and methods of preparing same
MXPA03004546A (es) * 2000-11-22 2003-09-10 Rxkinetix Inc Tratamiento de mucositis.
SE0100158D0 (sv) * 2001-01-19 2001-01-19 Synphora Ab Novel method and composition for local treatment of Meniere´s disease and tinnitus
US20050171054A1 (en) * 2001-01-19 2005-08-04 Helge Rask-Andersen Novel method and composition for local treatment of meniere's disease, tinnitus and/or hearing loss
ITMI20010913A1 (it) * 2001-05-04 2002-11-04 Univ Pavia Composizioni a rilascio controllato di acido lattico a livello vaginale
WO2002098404A1 (fr) * 2001-06-01 2002-12-12 Tendskin Company Compositions topiques pour utilisations en medecine veterinaire
US6897348B2 (en) 2001-12-19 2005-05-24 Kimberly Clark Worldwide, Inc Bandage, methods of producing and using same
US6967261B1 (en) 2001-12-28 2005-11-22 Kimberly-Clark Worldwide Bandage, methods of producing and using same
US6861066B2 (en) * 2002-03-11 2005-03-01 Health Plus International Inc. Method for the delivery of a biologically active agent
US20060280761A1 (en) * 2002-03-11 2006-12-14 Health Plus International, Inc. Nanofluidized B-12 composition and process for treating pernicious anemia
AT411769B (de) * 2002-07-12 2004-05-25 Chemiefaser Lenzing Ag Verfahren zur herstellung cellulosischer formkörper
US7265097B2 (en) 2002-08-20 2007-09-04 Chitogenics, Inc. Methods of drug delivery using sulphated chitinous polymers
EP1402862B1 (fr) * 2002-09-24 2007-11-28 The Procter & Gamble Company Article absorbant avec un element absorbant de composition thermoplastique absorbante pour des liquides
NZ540318A (en) * 2002-10-31 2007-09-28 Umd Inc Therapeutic compositions for drug delivery to and through covering epithelia
US8834864B2 (en) * 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US20050118261A1 (en) * 2003-06-12 2005-06-02 Oien Hal J. Compositions and methods of administering doxepin to mucosal tissue
WO2004112850A1 (fr) * 2003-06-20 2004-12-29 Johnson & Johnson Medical Limited Materiaux de pansement antioxydants
GB2402882B (en) * 2003-06-20 2007-03-28 Johnson & Johnson Medical Ltd Antioxidant wound dressing materials
GB2408206B (en) 2003-11-18 2007-11-28 Johnson & Johnson Medical Ltd Antioxidant and antimicrobial wound dressing materials
US20050036953A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of ammonium lactate
US20050042182A1 (en) * 2003-08-13 2005-02-24 Moshe Arkin Topical compositions of urea
US20050037040A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of urea and ammonium lactate
US20050025833A1 (en) * 2003-07-16 2005-02-03 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20050042268A1 (en) * 2003-07-16 2005-02-24 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20050020552A1 (en) * 2003-07-16 2005-01-27 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
WO2005016307A1 (fr) * 2003-07-30 2005-02-24 Stiefel Laboratories, Inc. Compositions steroidiques contenant des acides hydroxycarboxyliques et procedes d'utilisation associes
US7927626B2 (en) * 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US20050112151A1 (en) * 2003-11-20 2005-05-26 Horng Liou L. Skin adherent hydrogels
DE102004007115A1 (de) * 2004-02-13 2005-08-25 Cognis Deutschland Gmbh & Co. Kg Chitosanhaltige Wundauflagen
CA2560268A1 (fr) * 2004-03-18 2005-09-29 Yanyun Zhao Films en lysozyme-chitosane
US20070104836A1 (en) * 2004-03-18 2007-05-10 State of Oregon acting by and through the State Board of Higher Education on behalf of Oregon Lysozyme-chitosan films
EP1579831A1 (fr) 2004-03-23 2005-09-28 The Procter & Gamble Company Article absorbant avec barrières laterales comprenant une composition thermoplastique susceptible d'absorber les liquides
WO2005107710A2 (fr) * 2004-05-06 2005-11-17 Ivrea Pharmaceuticals, Inc. Particules pour la liberation d'agents actifs
DE502004011941D1 (de) * 2004-12-22 2011-01-05 Mestex Ag Mischung eines vanilloidrezeptoragonisten mit einer nervenregenerationshemmenden substanz, ihre verwendung für die herstellung eines schmerzmittels und verfahren zur applikation dieses mittels
US7638477B2 (en) * 2005-03-09 2009-12-29 Alberto-Culver Company Sustained-release fragrance delivery system
CN1833732A (zh) * 2005-03-17 2006-09-20 李毅彬 一种抗菌医用敷料的制造方法及其用途
WO2007016146A2 (fr) * 2005-07-28 2007-02-08 Macrochem Corporation Procede permettant de retarder la vitesse de distribution systemique pour des agents actifs facilement absorbables
ES3012497T3 (en) 2005-10-12 2025-04-09 Besins Healthcare Lu Sarl Improved testosterone gel and method of use
WO2007064755A2 (fr) * 2005-11-30 2007-06-07 Endo Pharmaceuticals Inc. Traitement de la xerostomie
WO2007091970A1 (fr) * 2006-02-06 2007-08-16 Synphora Ab Nouvelles méthode et compositions pour traiter un acouphène
MX2008014847A (es) * 2006-05-31 2009-04-30 Baxter Int Metodo para crecimiento interno en la celula dirigido y regeneracion controlada de los tejidos en la cirugia espinal.
US20110135742A1 (en) * 2006-06-20 2011-06-09 The Regents Of The University Of California Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles
TWI436793B (zh) * 2006-08-02 2014-05-11 巴克斯特國際公司 快速作用之乾密封膠及其使用和製造方法
CN101522164B (zh) * 2006-09-13 2014-03-26 提升肤质产品公司 用于治疗皮肤的化妆品组合物及其方法
US8114159B2 (en) 2006-11-20 2012-02-14 Depuy Spine, Inc. Anterior spinal vessel protector
EP1958613A1 (fr) * 2007-02-15 2008-08-20 Polichem S.A. Formulations liquides filmogènes pour la libération des médicaments sur la peau
WO2009006212A1 (fr) * 2007-06-29 2009-01-08 Union Carbide Chemicals & Plastics Technology Llc Films de soins personnels pour le coiffage et le conditionnement des cheveux
CA2691272A1 (fr) * 2007-06-29 2009-01-08 Union Carbide Chemicals & Plastics Technology Llc Coiffure et films de soins personnels de conditionnement capillaire
CL2008003219A1 (es) 2007-10-30 2009-10-09 Baxter Int Uso de una biomatriz de colageno biofuncional, multicapas y no porosa, que dirige el crecimiento celular dentro de los intersticios de la biomatriz de colageno, para tratar un defecto de una membrana visceral o parietal; y biomatriz utilizada.
WO2009058135A1 (fr) * 2007-10-30 2009-05-07 Celonova Biosciences, Inc. Microparticules polymères chargeables pour une utilisation thérapeutique en cas d'alopécie et leurs procédés de préparation et d'utilisation
US9314524B2 (en) * 2007-12-31 2016-04-19 Calla Therapeutics Llc Topical formulations of Flucytosine
CN102014973A (zh) 2008-02-29 2011-04-13 弗罗桑医疗设备公司 用于促进止血和/或伤口愈合的装置
AU2009244462B2 (en) 2008-05-06 2013-04-11 Cook Medical Technologies Llc Apparatus and methods for delivering therapeutic agents
US8729108B2 (en) * 2008-06-17 2014-05-20 Christopher J Dannaker Waterborne topical compositions for the delivery of active ingredients such as azelaic acid
AT507386A1 (de) * 2008-09-22 2010-04-15 Chemiefaser Lenzing Ag Verfahren zur behandlung cellulosischer formkörper
AT507387A1 (de) * 2008-09-22 2010-04-15 Chemiefaser Lenzing Ag Verwendung von lyocellfasern sowie lyocellfasern enthaltenden artikeln
US8916542B2 (en) * 2008-11-12 2014-12-23 Synedgen, Inc. Chitosan derivatives, compositions and related methods of use
WO2010069519A1 (fr) 2008-12-18 2010-06-24 Merz Pharma Gmbh & Co. Kgaa Compositions topiques comprenant au moins un ingrédient actif difficilement soluble dans l'eau et des biopolymères, tels que l'acide hyaluronique, présentant une valeur pka située entre 5 et 7
JP5631332B2 (ja) 2008-12-23 2014-11-26 クック メディカル テクノロジーズ エルエルシーＣｏｏｋ Ｍｅｄｉｃａｌ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｌｌｃ 治療薬を収容及び送達するための器械及び方法
WO2010109423A1 (fr) * 2009-03-25 2010-09-30 Sulur Subramaniam Vanangamudi Crème médicinale antifongique à base de stéroïdes et comprenant du chitosane, et son procédé de fabrication
WO2010109421A1 (fr) * 2009-03-25 2010-09-30 Sulur Subramaniam Vanangamudi Crème médicinale antifongique à base de stéroïdes et comprenant du chitosane, et son procédé de fabrication
WO2010109424A1 (fr) * 2009-03-25 2010-09-30 Sulur Subramaniam Vanangamudi Crème médicinale antibactérienne renfermant des stéroïdes et du chitosane, et son procédé de production
WO2010109434A2 (fr) * 2009-03-25 2010-09-30 Sulur Subramaniam Vanangamudi Crème médicinale antibactérienne, antifongique et contenant des stéroïdes, et procédé pour la préparer
US20120270835A1 (en) * 2009-04-13 2012-10-25 Apex Laboratories Private Limited Medicinal Cream Made Using Hydrocortisone Acetate and A Process To Make The Same
US8546362B2 (en) 2009-04-13 2013-10-01 Vanangamudi Subramaniam Sulur Medicinal cream made using neomycin sulphate, betamethasone valerate, and chitosan, and a process to make the same
WO2010119383A1 (fr) * 2009-04-13 2010-10-21 Vanangamudi Sulur Subramaniam Crème médicinale fabriquée à l'aide de crème de sulfate de framycétine et de chitosane, et procédé pour la fabriquer
WO2010122478A1 (fr) * 2009-04-20 2010-10-28 Sulur Subramaniam Vanangamudi Crème médicinale à base de stéroïdes et d'agents antibactériens incorporant un biopolymère et son procédé de fabrication
WO2010122474A2 (fr) * 2009-04-20 2010-10-28 Sulur Subramaniam Vanangamudi Crème médicinale antifongique et stéroïdique incorporant un biopolymère, et son procédé de fabrication
WO2010122477A1 (fr) * 2009-04-20 2010-10-28 Sulur Subramaniam Vanangamudi Crème stéroïde médicale antibactérienne et antifongique incorporant un biopolymère, et procédé de fabrication de celle-ci
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
US8118777B2 (en) 2009-05-29 2012-02-21 Cook Medical Technologies Llc Systems and methods for delivering therapeutic agents
US9101744B2 (en) 2009-05-29 2015-08-11 Cook Medical Technologies Llc Systems and methods for delivering therapeutic agents
BRPI1015979A8 (pt) * 2009-06-16 2018-06-19 Baxter Healthcare Sa esponja porosa hemostática, e, método para fabricar uma esponja porosa hemostática
EP2451845B1 (fr) * 2009-07-07 2017-03-01 Camlin Fine Sciences Limited Conservateurs issus de dérivés de chitine
US8771258B2 (en) 2009-12-16 2014-07-08 Baxter International Inc. Hemostatic sponge
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
ES2676208T3 (es) 2010-06-01 2018-07-17 Baxter International Inc. Proceso para la producción de composiciones hemostáticas secas y estables
KR101957625B1 (ko) 2010-06-01 2019-03-12 백스터 인터내셔널 인코포레이티드 건조 및 안정한 지혈 조성물의 제조 방법
CA2801120C (fr) 2010-06-01 2019-08-20 Baxter International Inc. Procede de fabrication de compositions hemostatiques sous forme seche et stable
ES2938566T3 (es) 2011-10-11 2023-04-12 Baxter Int Composiciones hemostaticas
JP6195569B2 (ja) 2011-10-11 2017-09-13 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 止血組成物
PT2771027E (pt) 2011-10-27 2015-11-26 Baxter Healthcare Sa Composições hemostáticas
RU2657955C2 (ru) 2012-03-06 2018-06-18 Ферросан Медикал Дивайсиз А/С Контейнер под давлением, содержащий гемостатическую пасту
GB201205174D0 (en) * 2012-03-23 2012-05-09 Medtrade Products Ltd Process for producing low endotoxin chitosan
EP2977066A3 (fr) 2012-06-12 2016-07-27 Ferrosan Medical Devices A/S Composition hémostatique sèche
GB201218954D0 (en) * 2012-10-22 2012-12-05 Norwegian University Of Life Sciences The Composition
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
US9867931B2 (en) 2013-10-02 2018-01-16 Cook Medical Technologies Llc Therapeutic agents for delivery using a catheter and pressure source
GB201309607D0 (en) * 2013-05-29 2013-07-10 Medtrade Products Ltd Process for producing low endotoxin chitosan
GB201309606D0 (en) * 2013-05-29 2013-07-10 Medtrade Products Ltd Process for producing low endotoxin chitosan
AU2014283170B2 (en) 2013-06-21 2017-11-02 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
US20170216341A1 (en) * 2016-01-28 2017-08-03 Oligo Médic Inc Composition comprising polyglucosamine-glyoxylate solutions mixed with hyaluronan
JP6489485B2 (ja) 2013-12-11 2019-03-27 フェロサン メディカル デバイシーズ エイ／エス 押し出し増強因子を含んでいる乾燥組成物
AU2015333206B2 (en) 2014-10-13 2019-07-11 Ferrosan Medical Devices A/S. Dry composition for use in haemostasis and wound healing
RU2705905C2 (ru) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Шприц для удерживания и смешивания первого и второго веществ
CN107771093B (zh) 2015-07-03 2021-06-15 弗罗桑医疗设备公司 用于混合两种组分和用于在存储条件下保持真空的注射器
US11801324B2 (en) 2018-05-09 2023-10-31 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition
CN115697176A (zh) 2020-06-05 2023-02-03 库克医学技术有限责任公司 用于递送治疗剂的医疗窥镜
WO2023287654A1 (fr) 2021-07-14 2023-01-19 Cook Medical Technologies, LLC Systèmes et méthodes pour empêcher l'obstruction d'un système d'administration
US12496429B2 (en) 2022-10-18 2025-12-16 Cook Medical Technologies Llc Systems and methods for delivering pressurized fluid to a target site alone or in conjunction with therapeutic agents

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2795579A (en) * 1953-10-09 1957-06-11 Warner Lambert Pharmaceutical Process for purification of chitosan by means of the salicylic acid salt thereof
US3953608A (en) * 1971-05-10 1976-04-27 L'oreal Cosmetic compositions for the skin containing a chitosan derivative
JPS5616532A (en) * 1979-07-20 1981-02-17 Kureha Chem Ind Co Ltd Production of formed porous article of chitin
US4424346A (en) * 1981-06-04 1984-01-03 Canadian Patents And Development Ltd. Derivatives of chitins, chitosans and other polysaccharides
US4365050A (en) * 1981-07-15 1982-12-21 Ivani Edward J Amino-polysaccharides and copolymers thereof for contact lenses and ophthalmic compositions
DE3245784A1 (de) * 1982-12-10 1984-06-14 Wella Ag, 6100 Darmstadt Kosmetisches mittel auf der basis von quaternaeren chitosanderivaten, neue quaternaere chitosanderivate sowie verfahren zu ihrer herstellung
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
GB2150833B (en) * 1983-12-08 1987-04-15 Ceskoslovenska Akademie Ved Proteolytic wounds dressing
US4532267A (en) * 1984-02-15 1985-07-30 Board Of Regents, University Of Washington Vision correction lens made from an aminopolysaccharide compound or an ether or ester thereof
US4659700A (en) * 1984-03-02 1987-04-21 Johnson & Johnson Products, Inc. Chitosan-glycerol-water gel
DE3501891A1 (de) * 1985-01-22 1986-07-24 Wella Ag, 6100 Darmstadt Kosmetische mittel auf der basis von quaternaeren chitosanderivaten, neue quaternaere hydroxypropyl-substituierte chitosanderivate sowie verfahren zu ihrer herstellung
DE3502833A1 (de) * 1985-01-29 1986-07-31 Wella Ag, 6100 Darmstadt Kosmetische mittel auf der basis von quaternaeren chitosanderivaten, neue quaternaere hydroxyethyl-substituierte chitosanderivate sowie verfahren zu ihrer herstellung
US4845204A (en) * 1985-02-07 1989-07-04 Wella Aktiengesellschaft Cosmetic compositions on the basis of alkyl-hydroxypropyl-substituted chitosan derivatives, new chitosan derivatives and processes for the production thereof
US4574150A (en) * 1985-02-19 1986-03-04 University Of Delaware Dry free-flowing water-soluble complexes of chitosan
DE3513277A1 (de) * 1985-04-13 1986-10-23 Wella Ag, 6100 Darmstadt Kosmetische mittel auf der basis von quaternaeren hydroxyalkyl-substituierten chitosanderivaten
DE3541305A1 (de) * 1985-11-22 1987-05-27 Wella Ag Kosmetische mittel auf der basis von n-hydroxypropylchitosanen, neue n-hydroxypropyl-chitosane sowie verfahren zu ihrer herstellung
DE3751938T2 (de) * 1986-06-06 1997-02-27 Union Carbide Corp Saure dekristallisierung von hochkristallin chitosan oder teilentacetylierten chitin
IT1219942B (it) * 1988-05-13 1990-05-24 Fidia Farmaceutici Esteri polisaccaridici

Also Published As

Publication number Publication date
EP0368253A2 (fr) 1990-05-16
US4946870A (en) 1990-08-07
AU625075B2 (en) 1992-07-02
EP0368253A3 (fr) 1991-09-25
KR910009240A (ko) 1991-06-28
CA2002404A1 (fr) 1990-05-08
AU4449789A (en) 1990-05-31
JPH02196728A (ja) 1990-08-03
KR940002657B1 (ko) 1994-03-28

Similar Documents

Publication Publication Date Title
IL92225A0 (en) Delivery systems containing aminopolysaccharide derivatives for the delivery of pharmaceutically active materials
AU8263987A (en) Pharmaceutical Delivery Systems
AU654515B2 (en) Delivery systems for pharmacological agents
AU576630B2 (en) Drug delivery system
AU6820687A (en) Drug delivery system
AU4989993A (en) Drug delivery system
AU5681294A (en) Tastemasked pharmaceutical materials
AU4648189A (en) Packaging for medicaments
AU591511B2 (en) Dispensing system with means for increasing delivery of beneficial agent from the system
AU3152993A (en) Improvements in the administration of aerosol compounds
AU3926589A (en) Pharmaceutical compounds exhibiting somatostatin-like activity
GB8813315D0 (en) Beam delivery system
AU2152788A (en) Dosage form for delivering diltiazem
AU5848386A (en) Agent delivery systems
AU7359487A (en) Receptor-targeted drug delivery systems
IL92268A0 (en) 14alpha,17alpha,ethanoestratriene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
AU3526193A (en) Dosage aerosols containing the active substance flezelastin and related structures
AU4758190A (en) Pharmaceutical preparation
AU1065088A (en) Pharmaceutical unit
AU3474289A (en) Pharmaceutical solutions of triamterene
EP0366614A3 (en) Pharmaceutically active dithioketene derivatives
AU5886390A (en) Pharmaceutically active derivative delivery systems
GB8830405D0 (en) Pharmaceutical formulation
AU5435994A (en) The use of inositoltrisphosphate for the preparation of medicaments
SG171194G (en) Pharmaceutically active dithioketene derivatives

Legal Events

Date Code Title Description
RH Patent void